Details of the Drug-Related molecule(s) Interaction Atlas

General Information of Drug (ID: DMEZ92A)

Drug Name

Hygromycin B Drug Info

Synonyms

AC1NUSSH

Indication

Disease Entry	ICD 11	Status	REF
Discovery agent	N.A.	Investigative	[1]

Cross-matching ID

Molecule-Related Drug Atlas

Molecule Type:

DTT

Drug Status:

Approved Drug(s)

Clinical Trial Drug(s)

Investigative Drug(s)

Download the Complete Related Drug List

Drug(s) Targeting Bacterial 16S ribosomal RNA (Bact 16S rRNA)

Drug Name	Drug ID	Indication	ICD 11	Highest Status	REF
Framycetin	DMF8DNE	Acute liver failure	DB91	Approved	[3]
Oxazolidinones	DMBM47Z	Gram-positive bacterial infection	1B74-1G40	Phase 2	[4]
Apramycin	DMU8QD2	Gram-negative bacterial infection	1B74-1G40	Phase 1	[1]
G418	DMKTJBU	Discovery agent	N.A.	Investigative	[1]
Ribostamycin	DMXWUHA	Discovery agent	N.A.	Investigative	[1]
Neamine	DMNCU6H	Discovery agent	N.A.	Investigative	[1]
Butirosin B	DMR6GJK	Discovery agent	N.A.	Investigative	[1]
Aminodeoxykanamycin	DM79E2K	Discovery agent	N.A.	Investigative	[1]
------------------------------------------------------------------------------------


⏷ Show the Full List of 8 Drug(s)

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Download the Complete Interaction Atlas for Visualization in Cytoscape

Drug Therapeutic Target (DTT)

DTT Name	DTT ID	UniProt ID	MOA	REF
Bacterial 16S ribosomal RNA (Bact 16S rRNA)	TT38DW5	NOUNIPROTAC	Inhibitor	[1]
Bacterial Ribosomal ATPase RbbA (Bact rbbA)	TTPEFM3	RBBA_ECOLI	Inhibitor	[2]

------------------------------------------------------------------------------------

References

1	RNA as a target for small molecules. Curr Opin Chem Biol. 2000 Dec;4(6):678-86.
2	A ribosomal ATPase is a target for hygromycin B inhibition on Escherichia coli ribosomes. Antimicrob Agents Chemother. 2001 Oct;45(10):2813-9.
3	Antistaphylococcal activity of gentamicin. Minerva Med. 1975 Dec 8;66(84):4505-26.
4	Ribosomal RNA is the target for oxazolidinones, a novel class of translational inhibitors. RNA. 1999 Jul;5(7):939-46.